Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease
- PMID: 11441129
Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease
Abstract
Wolman disease results from an inherited deficiency of lysosomal acid lipase (LAL; EC 3.1.1.13). This enzyme is essential for the hydrolysis of cholesteryl esters and triacylglycerols derived from endocytosed lipoproteins. Because of a complete absence of LAL activity, Wolman patients accumulate progressive amounts of cholesteryl esters and triacylglycerols in affected tissues. To investigate the nature of the genetic defects causing this disease, mutations in the LAL gene from three subjects of Moslem-Arab and Russian descent living in Israel were determined. Two homozygotes for a novel 1-bp deletion introducing a premature in-frame termination codon at amino acid position 106 (S106X) were identified. A third subject was a homozygote for a G-5R signal peptide substitution and a G60V missense mutation. The functional significance of these mutations was tested by in vitro expression of single and double mutants in Spodoptera frugiperda cells. Single mutants G60V and S106X and double mutant G-5R/G60V displayed a virtual absence of lipase activity in cell extracts and culture medium. Signal peptide mutant G-5R retained lipase activity in cell extracts and showed a drastically reduced enzyme activity in culture supernatant, indicating that the mutation may affect secretion of active enzyme from cells. These results support the notion that Wolman disease is a genetically heterogeneous disorder of lipid metabolism.
Similar articles
-
[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].Nihon Rinsho. 1995 Dec;53(12):3004-8. Nihon Rinsho. 1995. PMID: 8577049 Review. Japanese.
-
A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.J Lipid Res. 1996 Aug;37(8):1761-5. J Lipid Res. 1996. PMID: 8864960
-
Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model of Wolman's disease.J Lipid Res. 1995 Oct;36(10):2212-8. J Lipid Res. 1995. PMID: 8576647
-
Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.Protein Expr Purif. 2015 Jun;110:22-9. doi: 10.1016/j.pep.2014.12.009. Epub 2015 Jan 22. Protein Expr Purif. 2015. PMID: 25620107
-
Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):99-106. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014. PMID: 24798600 Review.
Cited by
-
Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing.BMC Med Genomics. 2016 May 13;9(1):24. doi: 10.1186/s12920-016-0184-7. BMC Med Genomics. 2016. PMID: 27175728 Free PMC article.
-
Functional Characterization of LIPA (Lysosomal Acid Lipase) Variants Associated With Coronary Artery Disease.Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2480-2491. doi: 10.1161/ATVBAHA.119.313443. Epub 2019 Oct 24. Arterioscler Thromb Vasc Biol. 2019. PMID: 31645127 Free PMC article.
-
Early steps in steroidogenesis: intracellular cholesterol trafficking.J Lipid Res. 2011 Dec;52(12):2111-2135. doi: 10.1194/jlr.R016675. Epub 2011 Oct 5. J Lipid Res. 2011. PMID: 21976778 Free PMC article. Review.
-
Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation.Eur J Pediatr. 2007 Jul;166(7):663-6. doi: 10.1007/s00431-006-0298-6. Epub 2006 Oct 11. Eur J Pediatr. 2007. PMID: 17033804
-
Translational Control of Secretory Proteins in Health and Disease.Int J Mol Sci. 2020 Apr 6;21(7):2538. doi: 10.3390/ijms21072538. Int J Mol Sci. 2020. PMID: 32268488 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials